Feline Coronaviruses: Pathogenesis of Feline Infectious Peritonitis

Advances in Virus Research

Volumn 96, Issue , 2016, Pages 193-218

  Tekes, G ^a   Thiel, H J ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Accessory proteins; Feline coronavirus; Feline enteric coronavirus; Feline infectious peritonitis; Reverse genetics

Indexed keywords

CORONAVIRUS SPIKE GLYCOPROTEIN; VIRAL PROTEIN; VIRUS RECEPTOR;

ANIMAL; CAT; EPITHELIUM CELL; FELINE CORONAVIRUS; FELINE INFECTIOUS PERITONITIS; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; MOLECULAR EVOLUTION; MUTATION; PATHOGENICITY; PATHOLOGY; REVERSE GENETICS; SEROTYPE; VIROLOGY; VIRULENCE; VIRUS GENOME;

ANIMALS; CATS; CORONAVIRUS, FELINE; EPITHELIAL CELLS; EVOLUTION, MOLECULAR; FELINE INFECTIOUS PERITONITIS; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HOST-PATHOGEN INTERACTIONS; MUTATION; RECEPTORS, VIRUS; REVERSE GENETICS; SEROGROUP; SPIKE GLYCOPROTEIN, CORONAVIRUS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRULENCE;

EID: 85016443465     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/bs.aivir.2016.08.002     Document Type: Chapter

References (126)

1. Addie, D.D., Jarrett, O., Control of feline coronavirus infection in kittens. Vet. Rec., 126, 1990, 164.
2. Addie, D.D., Jarrett, O., A study of naturally occurring feline coronavirus infections in kittens. Vet. Rec. 130 (1992), 133–137.
3. Addie, D.D., Schaap, I.A., Nicolson, L., Jarrett, O., Persistence and transmission of natural type I feline coronavirus infection. J. Gen. Virol. 84 (2003), 2735–2744.
4. Amer, A., Siti Suri, A., Abdul Rahman, O., Mohd, H.B., Faruku, B., Saeed, S., et al. Isolation and molecular characterization of type I and type II feline coronavirus in Malaysia. Virol. J., 9, 2012, 278.
5. An, D.J., Jeoung, H.Y., Jeong, W., Park, J.Y., Lee, M.H., Park, B.K., Prevalence of Korean cats with natural feline coronavirus infections. Virol. J., 8, 2011, 455.
6. Balint, A., Farsang, A., Zadori, Z., Hornyak, A., Dencso, L., Almazan, F., et al. Molecular characterization of feline infectious peritonitis virus strain DF-2 and studies of the role of ORF3abc in viral cell tropism. J. Virol. 86 (2012), 6258–6267.
7. Balint, A., Farsang, A., Szeredi, L., Zadori, Z., Belak, S., Recombinant feline coronaviruses as vaccine candidates confer protection in SPF but not in conventional cats. Vet. Microbiol. 169 (2014), 154–162.
8. Balint, A., Farsang, A., Zadori, Z., Belak, S., Comparative in vivo analysis of recombinant type II feline coronaviruses with truncated and completed ORF3 region. PLoS One, 9, 2014, e88758.
9. Bank-Wolf, B.R., Stallkamp, I., Wiese, S., Moritz, A., Tekes, G., Thiel, H.J., Mutations of 3c and spike protein genes correlate with the occurrence of feline infectious peritonitis. Vet. Microbiol. 173 (2014), 177–188.
10. Barker, E.N., Tasker, S., Gruffydd-Jones, T.J., Tuplin, C.K., Burton, K., Porter, E., et al. Phylogenetic analysis of feline coronavirus strains in an epizootic outbreak of feline infectious peritonitis. J. Vet. Intern. Med. 27 (2013), 445–450.
11. Benetka, V., Kubber-Heiss, A., Kolodziejek, J., Nowotny, N., Hofmann-Parisot, M., Mostl, K., Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis. Vet. Microbiol. 99 (2004), 31–42.
12. Black, J.W., Recovery and in vitro cultivation of a coronavirus from laboratory-induced cases of feline infectious peritonitis (FIP). Vet. Med. Small Anim. Clin. 75 (1980), 811–814.
13. Bosch, B.J., Rottier, P.J., Nidovirus entry into cells. Perlman, S., Gallagher, T., Snijder, E., (eds.) Nidoviruses, 2008, ASM Press, Washington, DC, 157–178.
14. Bosch, B.J., van der Zee, R., de Haan, C.A., Rottier, P.J., The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77 (2003), 8801–8811.
15. Brown, M.A., Troyer, J.L., Pecon-Slattery, J., Roelke, M.E., O'Brien, S.J., Genetics and pathogenesis of feline infectious peritonitis virus. Emerg. Infect. Dis. 15 (2009), 1445–1452.
16. Casais, R., Thiel, V., Siddell, S.G., Cavanagh, D., Britton, P., Reverse genetics system for the avian coronavirus infectious bronchitis virus. J. Virol. 75 (2001), 12359–12369.
17. Chang, H.W., de Groot, R.J., Egberink, H.F., Rottier, P.J., Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J. Gen. Virol. 91 (2010), 415–420.
18. Chang, H.W., Egberink, H.F., Rottier, P.J., Sequence analysis of feline coronaviruses and the circulating virulent/avirulent theory. Emerg. Infect. Dis. 17 (2011), 744–746.
19. Chang, H.W., Egberink, H.F., Halpin, R., Spiro, D.J., Rottier, P.J., Spike protein fusion peptide and feline coronavirus virulence. Emerg. Infect. Dis. 18 (2012), 1089–1095.
20. Coley, S.E., Lavi, E., Sawicki, S.G., Fu, L., Schelle, B., Karl, N., et al. Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo. J. Virol. 79 (2005), 3097–3106.
21. de Groot, R.J., Andeweg, A.C., Horzinek, M.C., Spaan, W.J., Sequence analysis of the 3′-end of the feline coronavirus FIPV 79-1146 genome: comparison with the genome of porcine coronavirus TGEV reveals large insertions. Virology 167 (1988), 370–376.
22. de Groot, R.J., Baker, S.C., Baric, R., Enjuanes, L., Gorbalenya, A.E., Holmes, K.V., et al. Family Coronaviridae. King, A.M.Q., Adams, M.J., Carstens, E.B., Lefkowitz, E.J., (eds.) Virus Taxonomy, 2012, Elsevier, Amsterdam, 806–828.
23. de Groot-Mijnes, J.D., van Dun, J.M., van der Most, R.G., de Groot, R.J., Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. J. Virol. 79 (2005), 1036–1044.
24. de Haan, C.A., Haijema, B.J., Boss, D., Heuts, F.W., Rottier, P.J., Coronaviruses as vectors: stability of foreign gene expression. J. Virol. 79 (2005), 12742–12751.
25. Dean, G.A., Olivry, T., Stanton, C., Pedersen, N.C., In vivo cytokine response to experimental feline infectious peritonitis virus infection. Vet. Microbiol. 97 (2003), 1–12.
26. Decaro, N., Buonavoglia, C., An update on canine coronaviruses: viral evolution and pathobiology. Vet. Microbiol. 132 (2008), 221–234.
27. Dedeurwaerder, A., Desmarets, L.M., Olyslaegers, D.A., Vermeulen, B.L., Dewerchin, H.L., Nauwynck, H.J., The role of accessory proteins in the replication of feline infectious peritonitis virus in peripheral blood monocytes. Vet. Microbiol. 162 (2013), 447–455.
28. Dedeurwaerder, A., Olyslaegers, D.A., Desmarets, L.M., Roukaerts, I.D., Theuns, S., Nauwynck, H.J., ORF7-encoded accessory protein 7a of feline infectious peritonitis virus as a counteragent against IFN-alpha-induced antiviral response. J. Gen. Virol. 95 (2014), 393–402.
29. Desmarets, L.M., Theuns, S., Olyslaegers, D.A., Dedeurwaerder, A., Vermeulen, B.L., Roukaerts, I.D., et al. Establishment of feline intestinal epithelial cell cultures for the propagation and study of feline enteric coronaviruses. Vet. Res., 44, 2013, 71.
30. Desmarets, L.M., Vermeulen, B.L., Theuns, S., Conceicao-Neto, N., Zeller, M., Roukaerts, I.D., et al. Experimental feline enteric coronavirus infection reveals an aberrant infection pattern and shedding of mutants with impaired infectivity in enterocyte cultures. Sci. Rep., 6, 2016, 20022.
31. Dewerchin, H.L., Cornelissen, E., Nauwynck, H.J., Replication of feline coronaviruses in peripheral blood monocytes. Arch. Virol. 150 (2005), 2483–2500.
32. Drechsler, Y., Alcaraz, A., Bossong, F.J., Collisson, E.W., Diniz, P.P., Feline coronavirus in multicat environments. Vet. Clin. North Am. Small Anim. Pract. 41 (2011), 1133–1169.
33. Dye, C., Siddell, S.G., Genomic RNA sequence of Feline coronavirus strain FIPV WSU-79/1146. J. Gen. Virol. 86 (2005), 2249–2253.
34. Dye, C., Temperton, N., Siddell, S.G., Type I feline coronavirus spike glycoprotein fails to recognize aminopeptidase N as a functional receptor on feline cell lines. J. Gen. Virol. 88 (2007), 1753–1760.
35. Foley, J.E., Poland, A., Carlson, J., Pedersen, N.C., Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus. J. Am. Vet. Med. Assoc. 210 (1997), 1313–1318.
36. Golovko, L., Lyons, L.A., Liu, H., Sorensen, A., Wehnert, S., Pedersen, N.C., Genetic susceptibility to feline infectious peritonitis in Birman cats. Virus Res. 175 (2013), 58–63.
37. Gunn-Moore, D.A., Gruffydd-Jones, T.J., Harbour, D.A., Detection of feline coronaviruses by culture and reverse transcriptase-polymerase chain reaction of blood samples from healthy cats and cats with clinical feline infectious peritonitis. Vet. Microbiol. 62 (1998), 193–205.
38. Haijema, B.J., Volders, H., Rottier, P.J., Switching species tropism: an effective way to manipulate the feline coronavirus genome. J. Virol. 77 (2003), 4528–4538.
39. Haijema, B.J., Volders, H., Rottier, P.J., Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J. Virol. 78 (2004), 3863–3871.
40. Haijema, B.J., Rottier, P.J.M., de Groot, R.J., Feline Coronaviruses: a tale of two-faced types. Thiel, V., (eds.) Coronaviruses: Molecular and Cellular Biology, 2007, Caister Academic Press, Norfolk, 182–203.
41. Hartmann, K., Feline infectious peritonitis. Vet. Clin. North Am. Small Anim. Pract. 35 (2005), 39–79.
42. Hayashi, T., Goto, N., Takahashi, R., Fujiwara, K., Systemic vascular lesions in feline infectious peritonitis. Nihon Juigaku Zasshi 39 (1977), 365–377.
43. Herrewegh, A.A., de Groot, R.J., Cepica, A., Egberink, H.F., Horzinek, M.C., Rottier, P.J., Detection of feline coronavirus RNA in feces, tissues, and body fluids of naturally infected cats by reverse transcriptase PCR. J. Clin. Microbiol. 33 (1995), 684–689.
44. Herrewegh, A.A., Vennema, H., Horzinek, M.C., Rottier, P.J., de Groot, R.J., The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes. Virology 212 (1995), 622–631.
45. Herrewegh, A.A., Mahler, M., Hedrich, H.J., Haagmans, B.L., Egberink, H.F., Horzinek, M.C., et al. Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology 234 (1997), 349–363.
46. Herrewegh, A.A., Smeenk, I., Horzinek, M.C., Rottier, P.J., de Groot, R.J., Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J. Virol. 72 (1998), 4508–4514.
47. Hofmann-Lehmann, R., Fehr, D., Grob, M., Elgizoli, M., Packer, C., Martenson, J.S., et al. Prevalence of antibodies to feline parvovirus, calicivirus, herpesvirus, coronavirus, and immunodeficiency virus and of feline leukemia virus antigen and the interrelationship of these viral infections in free-ranging lions in east Africa. Clin. Diagn. Lab. Immunol. 3 (1996), 554–562.
48. Hohdatsu, T., Okada, S., Ishizuka, Y., Yamada, H., Koyama, H., The prevalence of types I and II feline coronavirus infections in cats. J. Vet. Med. Sci. 54 (1992), 557–562.
49. Hohdatsu, T., Izumiya, Y., Yokoyama, Y., Kida, K., Koyama, H., Differences in virus receptor for type I and type II feline infectious peritonitis virus. Arch. Virol. 143 (1998), 839–850.
50. Hsieh, L.E., Chueh, L.L., Identification and genotyping of feline infectious peritonitis-associated single nucleotide polymorphisms in the feline interferon-gamma gene. Vet. Res., 45, 2014, 57.
51. Hsieh, L.E., Huang, W.P., Tang, D.J., Wang, Y.T., Chen, C.T., Chueh, L.L., 3C protein of feline coronavirus inhibits viral replication independently of the autophagy pathway. Res. Vet. Sci. 95 (2013), 1241–1247.
52. Kennedy, M., Boedeker, N., Gibbs, P., Kania, S., Deletions in the 7a ORF of feline coronavirus associated with an epidemic of feline infectious peritonitis. Vet. Microbiol. 81 (2001), 227–234.
53. Kennedy, M., Citino, S., McNabb, A.H., Moffatt, A.S., Gertz, K., Kania, S., Detection of feline coronavirus in captive Felidae in the USA. J. Vet. Diagn. Invest. 14 (2002), 520–522.
54. Kennedy, M., Abd-Eldaim, M., Zika, S.E., Mankin, J.M., Kania, S.A., Evaluation of antibodies against feline coronavirus 7b protein for diagnosis of feline infectious peritonitis in cats. Am. J. Vet. Res. 69 (2008), 1179–1182.
55. Kenny, A.J., Maroux, S., Topology of microvillar membrance hydrolases of kidney and intestine. Physiol. Rev. 62 (1982), 91–128.
56. Kipar, A., Meli, M.L., Feline infectious peritonitis: still an enigma?. Vet. Pathol. 51 (2014), 505–526.
57. Kipar, A., Bellmann, S., Kremendahl, J., Kohler, K., Reinacher, M., Cellular composition, coronavirus antigen expression and production of specific antibodies in lesions in feline infectious peritonitis. Vet. Immunol. Immunopathol. 65 (1998), 243–257.
58. Kipar, A., Kremendahl, J., Addie, D.D., Leukert, W., Grant, C.K., Reinacher, M., Fatal enteritis associated with coronavirus infection in cats. J. Comp. Pathol. 119 (1998), 1–14.
59. Kipar, A., May, H., Menger, S., Weber, M., Leukert, W., Reinacher, M., Morphologic features and development of granulomatous vasculitis in feline infectious peritonitis. Vet. Pathol. 42 (2005), 321–330.
60. Kipar, A., Baptiste, K., Barth, A., Reinacher, M., Natural FCoV infection: cats with FIP exhibit significantly higher viral loads than healthy infected cats. J. Feline Med. Surg. 8 (2006), 69–72.
61. Kipar, A., Meli, M.L., Failing, K., Euler, T., Gomes-Keller, M.A., Schwartz, D., et al. Natural feline coronavirus infection: differences in cytokine patterns in association with the outcome of infection. Vet. Immunol. Immunopathol. 112 (2006), 141–155.
62. Kipar, A., Meli, M.L., Baptiste, K.E., Bowker, L.J., Lutz, H., Sites of feline coronavirus persistence in healthy cats. J. Gen. Virol. 91 (2010), 1698–1707.
63. Kiss, I., Poland, A.M., Pedersen, N.C., Disease outcome and cytokine responses in cats immunized with an avirulent feline infectious peritonitis virus (FIPV)-UCD1 and challenge-exposed with virulent FIPV-UCD8. J. Feline Med. Surg. 6 (2004), 89–97.
64. Kubo, H., Yamada, Y.K., Taguchi, F., Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 68 (1994), 5403–5410.
65. Kummrow, M., Meli, M.L., Haessig, M., Goenczi, E., Poland, A., Pedersen, N.C., et al. Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin. Diagn. Lab. Immunol. 12 (2005), 1209–1215.
66. Leutenegger, C.M., Hofmann-Lehmann, R., Riols, C., Liberek, M., Worel, G., Lups, P., et al. Viral infections in free-living populations of the European wildcat. J. Wildl. Dis. 35 (1999), 678–686.
67. Lewis, C.S., Porter, E., Matthews, D., Kipar, A., Tasker, S., Helps, C.R., et al. Genotyping coronaviruses associated with feline infectious peritonitis. J. Gen. Virol. 96 (2015), 1358–1368.
68. Licitra, B.N., Millet, J.K., Regan, A.D., Hamilton, B.S., Rinaldi, V.D., Duhamel, G.E., et al. Mutation in spike protein cleavage site and pathogenesis of feline coronavirus. Emerg. Infect. Dis. 19 (2013), 1066–1073.
69. Lin, C.N., Su, B.L., Huang, H.P., Lee, J.J., Hsieh, M.W., Chueh, L.L., Field strain feline coronaviruses with small deletions in ORF7b associated with both enteric infection and feline infectious peritonitis. J. Feline Med. Surg. 11 (2009), 413–419.
70. Lin, C.N., Chang, R.Y., Su, B.L., Chueh, L.L., Full genome analysis of a novel type II feline coronavirus NTU156. Virus Genes 46 (2013), 316–322.
71. Look, A.T., Ashmun, R.A., Shapiro, L.H., Peiper, S.C., Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J. Clin. Invest. 83 (1989), 1299–1307.
72. Lorusso, A., Decaro, N., Schellen, P., Rottier, P.J., Buonavoglia, C., Haijema, B.J., et al. Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein. J. Virol. 82 (2008), 10312–10317.
73. Meli, M., Kipar, A., Muller, C., Jenal, K., Gonczi, E., Borel, N., et al. High viral loads despite absence of clinical and pathological findings in cats experimentally infected with feline coronavirus (FCoV) type I and in naturally FCoV-infected cats. J. Feline Med. Surg. 6 (2004), 69–81.
74. Munson, L., Marker, L., Dubovi, E., Spencer, J.A., Evermann, J.F., O'Brien, S.J., Serosurvey of viral infections in free-ranging Namibian cheetahs (Acinonyx jubatus). J. Wildl. Dis. 40 (2004), 23–31.
75. Narayanan, K., Huang, C., Makino, S., Coronavirus accessory proteins. Perlman, S., Gallagher, T., Snijder, E., (eds.) Nidoviruses, 2008, ASM Press, Washington, DC, 235–244.
76. Olyslaegers, D.A., Dedeurwaerder, A., Desmarets, L.M., Vermeulen, B.L., Dewerchin, H.L., Nauwynck, H.J., Altered expression of adhesion molecules on peripheral blood leukocytes in feline infectious peritonitis. Vet. Microbiol. 166 (2013), 438–449.
77. Oostra, M., de Haan, C.A., de Groot, R.J., Rottier, P.J., Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M. J. Virol. 80 (2006), 2326–2336.
78. Paul-Murphy, J., Work, T., Hunter, D., McFie, E., Fjelline, D., Serologic survey and serum biochemical reference ranges of the free-ranging mountain lion (Felis concolor) in California. J. Wildl. Dis. 30 (1994), 205–215.
79. Pedersen, N.C., Virologic and immunologic aspects of feline infectious peritonitis virus infection. Adv. Exp. Med. Biol. 218 (1987), 529–550.
80. Pedersen, N.C., A review of feline infectious peritonitis virus infection: 1963–2008. J. Feline Med. Surg. 11 (2009), 225–258.
81. Pedersen, N.C., An update on feline infectious peritonitis: virology and immunopathogenesis. Vet. J. 201 (2014), 123–132.
82. Pedersen, N.C., Black, J.W., Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus. Am. J. Vet. Res. 44 (1983), 229–234.
83. Pedersen, N.C., Boyle, J.F., Floyd, K., Infection studies in kittens, using feline infectious peritonitis virus propagated in cell culture. Am. J. Vet. Res. 42 (1981), 363–367.
84. Pedersen, N.C., Boyle, J.F., Floyd, K., Fudge, A., Barker, J., An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am. J. Vet. Res. 42 (1981), 368–377.
85. Pedersen, N.C., Evermann, J.F., McKeirnan, A.J., Ott, R.L., Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. Am. J. Vet. Res. 45 (1984), 2580–2585.
86. Pedersen, N.C., Allen, C.E., Lyons, L.A., Pathogenesis of feline enteric coronavirus infection. J. Feline Med. Surg. 10 (2008), 529–541.
87. Pedersen, N.C., Liu, H., Dodd, K.A., Pesavento, P.A., Significance of coronavirus mutants in feces and diseased tissues of cats suffering from feline infectious peritonitis. Viruses 1 (2009), 166–184.
88. Pedersen, N.C., Liu, H., Scarlett, J., Leutenegger, C.M., Golovko, L., Kennedy, H., et al. Feline infectious peritonitis: role of the feline coronavirus 3c gene in intestinal tropism and pathogenicity based upon isolates from resident and adopted shelter cats. Virus Res. 165 (2012), 17–28.
89. Pesteanu-Somogyi, L.D., Radzai, C., Pressler, B.M., Prevalence of feline infectious peritonitis in specific cat breeds. J. Feline Med. Surg. 8 (2006), 1–5.
90. Poland, A.M., Vennema, H., Foley, J.E., Pedersen, N.C., Two related strains of feline infectious peritonitis virus isolated from immunocompromised cats infected with a feline enteric coronavirus. J. Clin. Microbiol. 34 (1996), 3180–3184.
91. Porter, E., Tasker, S., Day, M.J., Harley, R., Kipar, A., Siddell, S.G., et al. Amino acid changes in the spike protein of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis. Vet. Res., 45, 2014, 49.
92. Regan, A.D., Whittaker, G.R., Utilization of DC-SIGN for entry of feline coronaviruses into host cells. J. Virol. 82 (2008), 11992–11996.
93. Regan, A.D., Cohen, R.D., Whittaker, G.R., Activation of p38 MAPK by feline infectious peritonitis virus regulates pro-inflammatory cytokine production in primary blood-derived feline mononuclear cells. Virology 384 (2009), 135–143.
94. Regan, A.D., Ousterout, D.G., Whittaker, G.R., Feline lectin activity is critical for the cellular entry of feline infectious peritonitis virus. J. Virol. 84 (2010), 7917–7921.
95. Rottier, P.J., Nakamura, K., Schellen, P., Volders, H., Haijema, B.J., Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J. Virol. 79 (2005), 14122–14130.
96. Semenza, G., Anchoring and biosynthesis of stalked brush border membrane proteins: glycosidases and peptidases of enterocytes and renal tubuli. Annu. Rev. Cell Biol. 2 (1986), 255–313.
97. Sharif, S., Arshad, S.S., Hair-Bejo, M., Omar, A.R., Zeenathul, N.A., Fong, L.S., et al. Descriptive distribution and phylogenetic analysis of feline infectious peritonitis virus isolates of Malaysia. Acta Vet. Scand., 52, 2010, 1.
98. Simons, F.A., Vennema, H., Rofina, J.E., Pol, J.M., Horzinek, M.C., Rottier, P.J., et al. A mRNA PCR for the diagnosis of feline infectious peritonitis. J. Virol. Methods 124 (2005), 111–116.
99. Stoddart, C.A., Scott, F.W., Intrinsic resistance of feline peritoneal macrophages to coronavirus infection correlates with in vivo virulence. J. Virol. 63 (1989), 436–440.
100. Takano, T., Hohdatsu, T., Hashida, Y., Kaneko, Y., Tanabe, M., Koyama, H., A “possible” involvement of TNF-alpha in apoptosis induction in peripheral blood lymphocytes of cats with feline infectious peritonitis. Vet. Microbiol. 119 (2007), 121–131.
101. Takano, T., Hohdatsu, T., Toda, A., Tanabe, M., Koyama, H., TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages. Virology 364 (2007), 64–72.
102. Takano, T., Azuma, N., Satoh, M., Toda, A., Hashida, Y., Satoh, R., et al. Neutrophil survival factors (TNF-alpha, GM-CSF, and G-CSF) produced by macrophages in cats infected with feline infectious peritonitis virus contribute to the pathogenesis of granulomatous lesions. Arch. Virol. 154 (2009), 775–781.
103. Takano, T., Ohyama, T., Kokumoto, A., Satoh, R., Hohdatsu, T., Vascular endothelial growth factor (VEGF), produced by feline infectious peritonitis (FIP) virus-infected monocytes and macrophages, induces vascular permeability and effusion in cats with FIP. Virus Res. 158 (2011), 161–168.
104. Tekes, G., Hofmann-Lehmann, R., Stallkamp, I., Thiel, V., Thiel, H.J., Genome organization and reverse genetic analysis of a type I feline coronavirus. J. Virol. 82 (2008), 1851–1859.
105. Tekes, G., Hofmann-Lehmann, R., Bank-Wolf, B., Maier, R., Thiel, H.J., Thiel, V., Chimeric feline coronaviruses that encode type II spike protein on type I genetic background display accelerated viral growth and altered receptor usage. J. Virol. 84 (2010), 1326–1333.
106. Tekes, G., Spies, D., Bank-Wolf, B., Thiel, V., Thiel, H.J., A reverse genetics approach to study feline infectious peritonitis. J. Virol. 86 (2012), 6994–6998.
107. Terada, Y., Matsui, N., Noguchi, K., Kuwata, R., Shimoda, H., Soma, T., et al. Emergence of pathogenic coronaviruses in cats by homologous recombination between feline and canine coronaviruses. PLoS One, 9, 2014, e106534.
108. Thiel, V., Herold, J., Schelle, B., Siddell, S.G., Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J. Gen. Virol. 82 (2001), 1273–1281.
109. Thiel, V., Thiel, H.J., Tekes, G., Tackling feline infectious peritonitis via reverse genetics. Bioengineered 5 (2014), 396–400.
110. Tresnan, D.B., Holmes, K.V., Feline aminopeptidase N is a receptor for all group I coronaviruses. Adv. Exp. Med. Biol. 440 (1998), 69–75.
111. Tresnan, D.B., Levis, R., Holmes, K.V., Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J. Virol. 70 (1996), 8669–8674.
112. Van Hamme, E., Desmarets, L., Dewerchin, H.L., Nauwynck, H.J., Intriguing interplay between feline infectious peritonitis virus and its receptors during entry in primary feline monocytes. Virus Res. 160 (2011), 32–39.
113. Vennema, H., Rossen, J.W., Wesseling, J., Horzinek, M.C., Rottier, P.J., Genomic organization and expression of the 3’ end of the canine and feline enteric coronaviruses. Virology 191 (1992), 134–140.
114. Vennema, H., Heijnen, L., Rottier, P.J., Horzinek, M.C., Spaan, W.J., A novel glycoprotein of feline infectious peritonitis coronavirus contains a KDEL-like endoplasmic reticulum retention signal. Adv. Exp. Med. Biol. 342 (1993), 209–214.
115. Vennema, H., Poland, A., Foley, J., Pedersen, N.C., Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 243 (1998), 150–157.
116. Vogel, L., Van der Lubben, M., te Lintelo, E.G., Bekker, C.P., Geerts, T., Schuijff, L.S., et al. Pathogenic characteristics of persistent feline enteric coronavirus infection in cats. Vet. Res., 41, 2010, 71.
117. Wang, K., Lu, W., Chen, J., Xie, S., Shi, H., Hsu, H., et al. PEDV ORF3 encodes an ion channel protein and regulates virus production. FEBS Lett. 586 (2012), 384–391.
118. Wang, Y.T., Su, B.L., Hsieh, L.E., Chueh, L.L., An outbreak of feline infectious peritonitis in a Taiwanese shelter: epidemiologic and molecular evidence for horizontal transmission of a novel type II feline coronavirus. Vet. Res., 44, 2013, 57.
119. Wang, Y.T., Hsieh, L.E., Dai, Y.R., Chueh, L.L., Polymorphisms in the feline TNFA and CD209 genes are associated with the outcome of feline coronavirus infection. Vet. Res., 45, 2014, 123.
120. Weiss, R.C., Scott, F.W., Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp. Immunol. Microbiol. Infect. Dis. 4 (1981), 175–189.
121. Weiss, R.C., Scott, F.W., Pathogenesis of feline infetious peritonitis: pathologic changes and immunofluorescence. Am. J. Vet. Res. 42 (1981), 2036–2048.
122. Worthing, K.A., Wigney, D.I., Dhand, N.K., Fawcett, A., McDonagh, P., Malik, R., et al. Risk factors for feline infectious peritonitis in Australian cats. J. Feline Med. Surg. 14 (2012), 405–412.
123. Yoo, D.W., Parker, M.D., Babiuk, L.A., The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells. Virology 180 (1991), 395–399.
124. Zhang, R., Wang, K., Lv, W., Yu, W., Xie, S., Xu, K., et al. The ORF4a protein of human coronavirus 229E functions as a viroporin that regulates viral production. Biochim. Biophys. Acta 1838 (2014), 1088–1095.
125. Ziebuhr, J., The coronavirus replicase. Curr. Top. Microbiol. Immunol. 287 (2005), 57–94.
126. Ziebuhr, J., Snijder, E.J., Gorbalenya, A.E., Virus-encoded proteinases and proteolytic processing in the Nidovirales. J. Gen. Virol. 81 (2000), 853–879.